Mittler R S, Bailey T S, Klussman K, Trailsmith M D, Hoffmann M K
Bristol-Myers Squibb Pharmaceutical Research Institute, Department of Immunology and Transplantation, Seattle, Washington 98121, USA.
J Exp Med. 1999 Nov 15;190(10):1535-40. doi: 10.1084/jem.190.10.1535.
The 4-1BB receptor (CDw137), a member of the tumor necrosis factor receptor superfamily, has been shown to costimulate the activation of T cells. Here we show that anti-mouse 4-1BB monoclonal antibodies (mAbs) inhibit thymus-dependent antibody production by B cells. Injection of anti-4-1BB mAbs into mice being immunized with cellular or soluble protein antigens induced long-term anergy of antigen-specific T cells. The immune response to the type II T cell-independent antigen trinintrophenol-conjugated Ficoll, however, was not suppressed. Inhibition of humoral immunity occurred only when anti-4-1BB mAb was given within 1 wk after immunization. Anti-4-1BB inhibition was observed in mice lacking functional CD8(+) T cells, indicating that CD8(+) T cells were not required for the induction of anergy. Analysis of the requirements for the anti-4-1BB-mediated inhibition of humoral immunity revealed that suppression could not be adoptively transferred with T cells from anti-4-1BB-treated mice. Transfer of BALB/c splenic T cells from sheep red blood cell (SRBC)-immunized and anti-4-1BB-treated mice together with normal BALB/c B cells into C.B-17 severe combined immunodeficient mice failed to generate an anti-SRBC response. However, B cells from the SRBC-immunized, anti-4-1BB-treated BALB/c mice, together with normal naive T cells, exhibited a normal humoral immune response against SRBC after transfer, demonstrating that SRBC-specific B cells were left unaffected by anti-4-1BB mAbs.
4-1BB受体(CDw137)是肿瘤坏死因子受体超家族的成员之一,已被证明可共刺激T细胞的活化。在此我们表明,抗小鼠4-1BB单克隆抗体(mAb)可抑制B细胞依赖胸腺的抗体产生。将抗4-1BB mAb注射到用细胞或可溶性蛋白抗原免疫的小鼠体内,可诱导抗原特异性T细胞长期无反应性。然而,对II型非T细胞依赖性抗原三硝基苯酚偶联的Ficoll的免疫反应并未受到抑制。体液免疫的抑制仅在免疫后1周内给予抗4-1BB mAb时才会发生。在缺乏功能性CD8(+) T细胞的小鼠中观察到抗4-1BB抑制作用,这表明诱导无反应性不需要CD8(+) T细胞。对抗4-1BB介导的体液免疫抑制的需求分析表明,抑制作用不能通过来自抗4-1BB处理小鼠的T细胞进行过继转移。将来自绵羊红细胞(SRBC)免疫和抗4-1BB处理小鼠的BALB/c脾T细胞与正常BALB/c B细胞一起转移到C.B-17严重联合免疫缺陷小鼠中,未能产生抗SRBC反应。然而,来自SRBC免疫、抗4-1BB处理的BALB/c小鼠的B细胞与正常幼稚T细胞一起转移后,对SRBC表现出正常的体液免疫反应,这表明SRBC特异性B细胞未受抗4-1BB mAb的影响。